Work

How Patents Flagged for Delisting Can Still Delay Generic Competition

Year: 2026

Type: article

Abstract: This Viewpoint discusses the legal entanglements that can block generic drug competition on patents flagged for delisting.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2026.3842

Authors: Sarah M. E. Gabriele, William B. Feldman

Institutions: Brigham and Women's Hospital, Harvard University, University of California, Los Angeles

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Peace, justice, and strong institutions

Open Access status: gold

Estimated APC paid: $5,000

OpenAlex ID: W7225376839

FWCI:

Cites: 3

Cited by:

Related to: 10